Persistence of non-vitamin K antagonist oral anticoagulant use in Japanese patients with atrial fibrillation: A single-center observational study
Background: Non-vitamin K antagonist oral anticoagulants (NOACs) show a favorable balance between efficacy and safety compared with warfarin for patients with non-valvular atrial fibrillation (NVAF). In “real-world” practice, however, NOAC adherence and persistence among patients are not clear. The...
Main Authors: | Tsuyoshi Shiga, MD, Miyoko Naganuma, BSc, Takehiko Nagao, MD, Kenji Maruyama, MD, Atsushi Suzuki, MD, Kagari Murasaki, MD, Nobuhisa Hagiwara, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-12-01
|
Series: | Journal of Arrhythmia |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1880427615000575 |
Similar Items
-
Effectiveness and safety of dabigatran versus warfarin in “real-world” Japanese patients with atrial fibrillation: A single-center observational study
by: Miyoko Naganuma, PhD, et al.
Published: (2017-04-01) -
Underutilization of anticoagulants in patients with nonvalvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants
by: Susin Park, et al.
Published: (2022-01-01) -
Warfarin or non-Vitamin K antagonist oral anticoagulants: Navigating the choice of oral anticoagulant drugs in the COVID-19 pandemic era
by: Heng Cai, et al.
Published: (2020-01-01) -
Characteristics of Novel Anticoagulants versus Vitamin K Antagonists in the Ventricular Mural Thrombus
by: Qing Yang, et al.
Published: (2023-03-01) -
Algorithm for the Choice of Anticoagulant for Patients with Atrial Fibrillation
by: Yu. P. Skirdenko, et al.
Published: (2020-05-01)